Transcription factor E3 renal cell carcinoma presenting as secondary hypertension

Abstract. Microphthalmia-associated transcription factor family (transcription factor E3 or transcription factor EB) translocation renal cell carcinomas (RCCs) are rare neoplasms. These renal neoplasms can be either asymptomatic and incidentally discovered on imaging or symptomatic, with the most co...

Full description

Bibliographic Details
Main Authors: Alain Mwamba Mukendi, Gerald Tatenda Mataruka, Ramesh Nadimpalli, Tshisola Miji Kasapato
Format: Article
Language:English
Published: Wolters Kluwer Health 2023-03-01
Series:Current Urology
Online Access:http://journals.lww.com/10.1097/CU9.0000000000000108
_version_ 1797690679746363392
author Alain Mwamba Mukendi
Gerald Tatenda Mataruka
Ramesh Nadimpalli
Tshisola Miji Kasapato
author_facet Alain Mwamba Mukendi
Gerald Tatenda Mataruka
Ramesh Nadimpalli
Tshisola Miji Kasapato
author_sort Alain Mwamba Mukendi
collection DOAJ
description Abstract. Microphthalmia-associated transcription factor family (transcription factor E3 or transcription factor EB) translocation renal cell carcinomas (RCCs) are rare neoplasms. These renal neoplasms can be either asymptomatic and incidentally discovered on imaging or symptomatic, with the most common presenting symptoms being hematuria, pain, and abdominal mass, or paraneoplastic event. In conventional RCCs, hypertension is considered a risk factor and a possible paraneoplastic event, whereas, in translocation RCCs, prior exposure to cytotoxic chemotherapy is the only known risk factor, and hypertension as an isolated associated paraneoplastic event has never been reported. Interestingly, hypertension as the only presenting symptom in RCC is extremely rare. We report a case of transcription factor E3 positive RCC in a young adult presenting only with hypertension that normalized after radical nephrectomy. To the best of our knowledge, this is the first reported case of hypertension secondary to microphthalmia-associated transcription translocation RCC.
first_indexed 2024-03-12T02:03:43Z
format Article
id doaj.art-ee5ef32b5ef24caba5371d9e3ae22d38
institution Directory Open Access Journal
issn 1661-7649
language English
last_indexed 2024-03-12T02:03:43Z
publishDate 2023-03-01
publisher Wolters Kluwer Health
record_format Article
series Current Urology
spelling doaj.art-ee5ef32b5ef24caba5371d9e3ae22d382023-09-07T09:31:01ZengWolters Kluwer HealthCurrent Urology1661-76492023-03-01171586110.1097/CU9.0000000000000108202303000-00011Transcription factor E3 renal cell carcinoma presenting as secondary hypertensionAlain Mwamba Mukendi0Gerald Tatenda Mataruka1Ramesh Nadimpalli2Tshisola Miji Kasapato3Thelle Mogoerane Regional Hospital, Division of Urology, Department of Surgery, University of the Witwatersrand, Johannesburg, South AfricaThelle Mogoerane Regional Hospital, Division of Urology, Department of Surgery, University of the Witwatersrand, Johannesburg, South AfricaThelle Mogoerane Regional Hospital, Division of Urology, Department of Surgery, University of the Witwatersrand, Johannesburg, South AfricaThelle Mogoerane Regional Hospital, Division of Urology, Department of Surgery, University of the Witwatersrand, Johannesburg, South AfricaAbstract. Microphthalmia-associated transcription factor family (transcription factor E3 or transcription factor EB) translocation renal cell carcinomas (RCCs) are rare neoplasms. These renal neoplasms can be either asymptomatic and incidentally discovered on imaging or symptomatic, with the most common presenting symptoms being hematuria, pain, and abdominal mass, or paraneoplastic event. In conventional RCCs, hypertension is considered a risk factor and a possible paraneoplastic event, whereas, in translocation RCCs, prior exposure to cytotoxic chemotherapy is the only known risk factor, and hypertension as an isolated associated paraneoplastic event has never been reported. Interestingly, hypertension as the only presenting symptom in RCC is extremely rare. We report a case of transcription factor E3 positive RCC in a young adult presenting only with hypertension that normalized after radical nephrectomy. To the best of our knowledge, this is the first reported case of hypertension secondary to microphthalmia-associated transcription translocation RCC.http://journals.lww.com/10.1097/CU9.0000000000000108
spellingShingle Alain Mwamba Mukendi
Gerald Tatenda Mataruka
Ramesh Nadimpalli
Tshisola Miji Kasapato
Transcription factor E3 renal cell carcinoma presenting as secondary hypertension
Current Urology
title Transcription factor E3 renal cell carcinoma presenting as secondary hypertension
title_full Transcription factor E3 renal cell carcinoma presenting as secondary hypertension
title_fullStr Transcription factor E3 renal cell carcinoma presenting as secondary hypertension
title_full_unstemmed Transcription factor E3 renal cell carcinoma presenting as secondary hypertension
title_short Transcription factor E3 renal cell carcinoma presenting as secondary hypertension
title_sort transcription factor e3 renal cell carcinoma presenting as secondary hypertension
url http://journals.lww.com/10.1097/CU9.0000000000000108
work_keys_str_mv AT alainmwambamukendi transcriptionfactore3renalcellcarcinomapresentingassecondaryhypertension
AT geraldtatendamataruka transcriptionfactore3renalcellcarcinomapresentingassecondaryhypertension
AT rameshnadimpalli transcriptionfactore3renalcellcarcinomapresentingassecondaryhypertension
AT tshisolamijikasapato transcriptionfactore3renalcellcarcinomapresentingassecondaryhypertension